LimmaTech Awarded FDA Fast Track Designation for Vaccine Candidate Against Staphylococcus aureus

Published on December 20, 2024

is backed by specialist healthcare investors, including Adjuvant Capital, AXA IM Alts, Novo Holdings REPAIR Impact Fund, and Tenmile. For